Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-25 @ 1:22 AM
NCT ID: NCT06076993
Eligibility Criteria: Inclusion Criteria: * Schools will be eligible if 1. they are a second-level school in Ireland that offers the Transition Year (TY) programme to students 2. will deliver the intervention as part of their curriculum to students in TY 3. teaching staff are willing to complete the 2.5-hour BodyKind teacher training programme. Students will be eligible if * they are in TY in a second-level school in Ireland and are aged 15-17 years * If their parent consents to their participation AND if they provide a signed assent form . Teachers will be eligible if * They are qualified secondary school teacher * They agree to complete the BodyKind teacher training * Return a signed informed consent form Exclusion Criteria: * Schools will be excluded if * they are not a second-level school in Ireland or if they do not offer the TY programme to students * will not deliver the intervention as part of their curriculum to students in TY * teaching staff are not willing to complete the 2.5-hour BodyKind teacher training programme. Students will be excluded if * they are not in TY in a second-level school and are not aged 15-17 years * If parental consent has not been obtained OR if they fail to sign a participant assent . Teachers will be excluded if * They are not qualified secondary school teacher * They do not agree to complete the BodyKind teacher training * Do not return a signed informed consent form
Healthy Volunteers: True
Sex: ALL
Minimum Age: 15 Years
Maximum Age: 17 Years
Study: NCT06076993
Study Brief:
Protocol Section: NCT06076993